1. Home
  2. GKOS vs ASB Comparison

GKOS vs ASB Comparison

Compare GKOS & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$122.45

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Associated Banc-Corp

ASB

Associated Banc-Corp

HOLD

Current Price

$28.07

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
ASB
Founded
1998
1861
Country
United States
United States
Employees
N/A
4000
Industry
Medical/Dental Instruments
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
ASB
Price
$122.45
$28.07
Analyst Decision
Strong Buy
Buy
Analyst Count
12
12
Target Price
$126.92
$29.75
AVG Volume (30 Days)
779.2K
1.7M
Earning Date
04-29-2026
04-23-2026
Dividend Yield
N/A
3.45%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
$21.24
Revenue Next Year
$27.43
$8.86
P/E Ratio
N/A
$10.23
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$22.48
52 Week High
$148.11
$29.52

Technical Indicators

Market Signals
Indicator
GKOS
ASB
Relative Strength Index (RSI) 40.86 53.71
Support Level $79.59 $27.23
Resistance Level $123.09 $28.02
Average True Range (ATR) 6.56 0.54
MACD -1.43 -0.07
Stochastic Oscillator 5.60 48.22

Price Performance

Historical Comparison
GKOS
ASB

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ASB Associated Banc-Corp

Associated Banc-Corp is a bank holding company based in the United States of America. The company, through its subsidiaries, provides a broad array of banking and non-banking products and services to individuals and businesses. The group operates in three reportable segments: Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty segment, which serves a wide range of customers, including larger businesses, developers, not-for-profits, municipalities, and financial institutions by providing lending and deposit solutions as well as support to deliver, fund, and manage such banking solutions.

Share on Social Networks: